This IRB approved study assessed the performance of Triage, an AI application, in determining the malignancy of lesions. The images were ran through the Triage application and the same images were assessed by primary care physicians and dermatologists. The top diagnosis given by the AI application was taken into account while the medical providers were asked to label the images as benign or malignant.